Hong Kong Water Utilities Stock News

SEHK:297
SEHK:297Chemicals

Assessing Sinofert Holdings (SEHK:297) Valuation After Strong 2025 Earnings Update

Why Sinofert Holdings' Latest Earnings Matter for Shareholders Sinofert Holdings (SEHK:297) just reported its full year 2025 results, with higher sales, net income, and earnings per share from continuing operations compared with the previous year, putting the fertilizer producer back in focus for investors. See our latest analysis for Sinofert Holdings. The latest full year results arrive after a mixed stretch for the share price, with a 1 month share price return of 16% decline and a 90 day...
SEHK:6831
SEHK:6831Hospitality

March 2026's Undervalued Asian Small Caps With Insider Action

As geopolitical tensions and energy price volatility continue to shape global market sentiment, Asian small-cap stocks are navigating a complex landscape influenced by these broader economic shifts. With key indices like the S&P MidCap 400 and Russell 2000 showing resilience amid fluctuating conditions, investors are increasingly focused on identifying opportunities within small-cap segments that may offer potential value amidst uncertainty. In this environment, a good stock is often...
SEHK:3939
SEHK:3939Metals and Mining

A Look At Wanguo Gold Group (SEHK:3939) Valuation After Strong 2025 Earnings And Higher Final Dividend

Earnings jump and higher dividend put Wanguo Gold Group in focus Wanguo Gold Group (SEHK:3939) has drawn fresh attention after reporting full year 2025 results, with sales and net income higher than a year earlier, alongside a proposed increase in its final ordinary dividend. See our latest analysis for Wanguo Gold Group. The latest update appears to have shifted sentiment quickly, with a 9.67% 1 day share price return and 23.61% 7 day share price return. The 1 year total shareholder return...
SEHK:6181
SEHK:6181Luxury

3 Asian Stocks Estimated To Be Trading Up To 48.5% Below Intrinsic Value

Amidst a backdrop of geopolitical tensions and fluctuating energy prices, Asian markets have experienced volatility as investors navigate the complexities of these global events. Despite these challenges, opportunities arise for discerning investors seeking undervalued stocks that may be trading below their intrinsic value, offering potential for growth when market conditions stabilize.
SEHK:1530
SEHK:1530Biotechs

3SBio (SEHK:1530) Valuation Check After Strong 2025 Sales And Earnings Growth

3SBio (SEHK:1530) just released full year 2025 results, reporting sales of CNY 17,695.75 million and net income of CNY 8,482.16 million, drawing fresh attention to the stock’s recent move. See our latest analysis for 3SBio. The earnings release follows a board meeting earlier in March that highlighted these results and a potential final dividend. The strong full year figures appear to align with fresh interest in the stock, with a 7 day share price return of 13.25% and a 1 year total...
SEHK:1919
SEHK:1919Shipping

A Look At COSCO SHIPPING Holdings (SEHK:1919) Valuation After Weaker Full Year 2025 Earnings

COSCO SHIPPING Holdings (SEHK:1919) reported full year 2025 results showing softer revenue and earnings, with sales of CNY 219.18b and net income of CNY 30.87b, shaping how investors reassess the container shipping group. See our latest analysis for COSCO SHIPPING Holdings. Despite softer revenue and earnings, COSCO SHIPPING Holdings' 1-day share price return of 1.33% and 90-day share price return of 9.16% come alongside a 1-year total shareholder return of 41.43% and very large 5-year gains,...
SEHK:1828
SEHK:1828Insurance

Is FWD Group Holdings (SEHK:1828) Overvalued After Strong Recent Share Price Returns?

Recent performance snapshot for FWD Group Holdings FWD Group Holdings (SEHK:1828) has seen its share price weaken recently, with a 2.1% decline over the past day, smaller losses over the past week, and deeper falls over the past month and the past 3 months. See our latest analysis for FWD Group Holdings. With the share price at HK$30.16, FWD Group Holdings has a 30 day share price return of 18.5% and a 90 day share price return of 20.6%, suggesting momentum has been fading compared with the...
SEHK:1117
SEHK:1117Food

China Modern Dairy Holdings (SEHK:1117) Valuation After 2025 Earnings And Board Appointment From Mengniu

China Modern Dairy Holdings (SEHK:1117) has drawn fresh attention after releasing its full year 2025 results, reporting lower net losses alongside reduced sales, and reshaping its board and capital structure on the same date. See our latest analysis for China Modern Dairy Holdings. The latest results and board changes have landed after a weak few months for the share price, with a 90 day share price return of negative 10.76% and year to date share price return of negative 12.96%. However, a 1...
SEHK:1585
SEHK:1585Auto

Yadea Group Holdings (SEHK:1585) Valuation Check After Strong 2025 Sales And Earnings Growth

Why Yadea Group Holdings Stock Is Back on Investors’ Radar Yadea Group Holdings (SEHK:1585) has drawn fresh attention after reporting full year 2025 results, with sales of CNY 37,008.24 million and net income of CNY 2,911.59 million, both higher than the prior year. See our latest analysis for Yadea Group Holdings. The earnings release on 30 March appears to have coincided with a sharp pickup in momentum, with a 1-day share price return of 5.19% and a 30-day share price return of 11.92%...
SEHK:9985
SEHK:9985Food

A Look At WEILONG Delicious Global Holdings (SEHK:9985) Valuation After Strong Full Year 2025 Results

WEILONG Delicious Global Holdings (SEHK:9985) has drawn fresh attention after reporting full year 2025 results, with sales of CN¥7,223.76 million and net income of CN¥1,425.2 million compared to the prior year. See our latest analysis for WEILONG Delicious Global Holdings. The latest full year earnings arrived after a weak run for shareholders, with the 1 year total shareholder return at a 34.02% loss and the 30 day share price return at a 17.34% loss, while the 3 year total shareholder...
SEHK:3698
SEHK:3698Banks

Huishang Bank (SEHK:3698) Valuation Check After Strong 2025 Earnings And Rising Investor Interest

Huishang Bank (SEHK:3698) has drawn fresh attention after reporting its full year 2025 earnings. The bank recorded net income of CN¥16,524.6 million and earnings per share of CN¥1.14 from continuing operations. See our latest analysis for Huishang Bank. The full year 2025 earnings release and the recent board meeting around the dividend appear to have coincided with stronger sentiment, with Huishang Bank’s 90 day share price return of 43.75% and 1 year total shareholder return of 85.38%...
SEHK:3337
SEHK:3337Energy Services

Anton Oilfield (SEHK:3337) Net Margin At 6.7% Tests Market Skepticism On Earnings Quality

Anton Oilfield Services Group (SEHK:3337) closed FY 2025 with fourth quarter revenue of C¥1.9b and net income of C¥143.2m, while trailing twelve month revenue came in at C¥5.6b with net income of C¥373.1m and EPS of C¥0.137. Over recent periods the company has seen quarterly revenue move from C¥1.1b in the third quarter of 2024 to C¥1.3b in the second quarter of 2025 and then to C¥1.9b in the fourth quarter of 2025. Over the same stretch, net income has ranged from C¥52.9m to C¥143.2m, with...
SEHK:3696
SEHK:3696Life Sciences

Insilico Medicine Cayman TopCo FY 2025 Loss Deepens To US$352.3 Million Challenging Bullish Narratives

InSilico Medicine Cayman TopCo (SEHK:3696) has opened FY 2025 with first half revenue of US$27.5 million and a basic EPS loss of US$0.25, while trailing twelve month figures show revenue of US$56.2 million alongside a net loss of US$352.3 million and EPS of US$4.48 in the red. Over the recent reported periods, the company has seen revenue shift from US$59.7 million in the first half of FY 2024 to US$26.1 million in the second half and then to US$27.5 million in the first half of FY 2025. Net...
SEHK:1440
SEHK:1440Luxury

Assessing Star Shine Holdings Group (SEHK:1440) Valuation After FY2025 Larger Loss Guidance And Mixed Business Updates

Star Shine Holdings Group (SEHK:1440) has put investors on alert with fresh guidance pointing to a larger FY2025 net loss, just ahead of its March 30 results announcement and the related board meeting. See our latest analysis for Star Shine Holdings Group. The earnings warning has shifted sentiment sharply in the short term, with a 10.83% 1 day share price return decline and a 6.38% 7 day pullback, despite a strong 90 day share price return of 89.75% and a very large 5 year total shareholder...
SEHK:3320
SEHK:3320Pharmaceuticals

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation After 2025 Results And Higher Dividend Proposal

China Resources Pharmaceutical Group (SEHK:3320) has come into focus after reporting full year 2025 results and hosting its earnings call, alongside a Board proposal to lift the final cash dividend compared with 2024. See our latest analysis for China Resources Pharmaceutical Group. The earnings release and higher proposed dividend appear to have coincided with a sharp improvement in sentiment, with a 7 day share price return of 28.67% and a 30 day share price return of 25.27% helping lift...
SEHK:3692
SEHK:3692Pharmaceuticals

Hansoh Pharmaceutical Group (SEHK:3692) Net Margin Strength Backs Bullish Narratives

Hansoh Pharmaceutical Group (SEHK:3692) just posted its FY 2025 first half results with revenue of C¥7.4b and basic EPS of C¥0.53, against a trailing twelve month backdrop of C¥15.0b in revenue and C¥0.93 in EPS off C¥5.6b in net income, as well as earnings growth of 27.1% over the past year. The company has seen revenue move from C¥6.5b and EPS of C¥0.46 in 1H FY 2024 to C¥5.8b and EPS of C¥0.28 in 2H FY 2024, and now to C¥7.4b and EPS of C¥0.53 in 1H FY 2025. This sets up a story where rich...
SEHK:9960
SEHK:9960Healthcare

Kindstar Globalgene Technology (SEHK:9960) Loss Narrows In 1H 2025 Challenging Bearish Narratives

Kindstar Globalgene Technology (SEHK:9960) has reported its FY 2025 first half results with revenue of C¥456.9 million and a basic EPS loss of C¥0.0378, while trailing 12 month figures show revenue of C¥933.6 million and a basic EPS loss of C¥0.0592. Over the past three half year periods, revenue has moved from C¥473.3 million in 1H 2024 to C¥454.2 million in 2H 2024 and C¥456.9 million in 1H 2025, alongside a shift in basic EPS from C¥0.0125 to a loss of C¥0.0706 and then a smaller loss of...